• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity.

作者信息

Bhattacharya S K, Sen A P

机构信息

Department of Pharmacology, Banaras Hindu University, Varanasi, India.

出版信息

J Neural Transm Gen Sect. 1992;90(3):241-7. doi: 10.1007/BF01250965.

DOI:10.1007/BF01250965
PMID:1283683
Abstract

The effects of some muscarinic M1 and M2 receptor agonists and antagonists on rat brain serotonergic activity was assessed by noting their effects on the levels of 5-hydroxytryptamine (5-HT) and its major metabolite, 5-hydroxyindole acetic acid (5-HIAA), estimated by a high pressure-liquid chromatographic (HPLC) technique. The muscarinic M1 receptor agonists, arecholine and McN-A-343, and the M2 receptor agonists, gallamine and AF-DX 116, induced a dose-related decrease in the concentrations of both 5-HT and 5-HIAA. On the contrary, scopolamine and the selective M1 receptor antagonist, pirenzepine, increased the levels of the amine and its metabolite. The anti-cholinesterase agent, physostigmine, and the putative M2 receptor agonist, carbachol, induced a dose-related dual effect, with the smaller doses decreasing and the higher doses increasing 5-HT and 5-HIAA concentrations. The results indicate that an inverse relationship exists between the cholinergic and serotonergic neurotransmitter systems in the rat brain due to the likely presence of muscarinic heteroreceptors on serotonergic neurones. The data also indicates that though physostigmine and carbachol may function as M2 receptor agonists, they lose their receptor specificity on dose increment.

摘要

相似文献

1
Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity.
J Neural Transm Gen Sect. 1992;90(3):241-7. doi: 10.1007/BF01250965.
2
Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats.选择性毒蕈碱受体激动剂和拮抗剂对大鼠主动回避学习获得的影响。
Indian J Exp Biol. 1991 Feb;29(2):136-9.
3
Thermic response of selective muscarinic agonists and antagonists in rat.
Indian J Exp Biol. 1991 Feb;29(2):131-5.
4
Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.毒蕈碱受体激动剂在兔输精管中的毒蕈碱M1受体激动作用。
Eur J Pharmacol. 1993 Feb 23;232(1):47-57. doi: 10.1016/0014-2999(93)90727-y.
5
Effects of muscarinic receptor agonists and antagonists on dopamine-mediated behavioural paradigms.毒蕈碱受体激动剂和拮抗剂对多巴胺介导的行为范式的影响。
J Neural Transm Gen Sect. 1991;84(3):241-6. doi: 10.1007/BF01244975.
6
Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype.毒蕈碱受体激动剂引起的中枢升压作用:M2受体亚型起主要作用的证据。
Eur J Pharmacol. 1986 Jun 5;125(1):63-70. doi: 10.1016/0014-2999(86)90083-x.
7
Central action of drugs acting on the cholinergic muscarinic receptor. IV. Influence of cholinomimetics and cholinolytics injected into the lateral cerebral ventricle in the rat on concentrations of 5-HT and 5-HIAA.作用于胆碱能毒蕈碱受体的药物的中枢作用。IV. 向大鼠侧脑室注射拟胆碱药和解胆碱药对5-羟色胺和5-羟吲哚乙酸浓度的影响。
Arch Immunol Ther Exp (Warsz). 1975;23(4):497-503.
8
Muscarinic receptor subtypes and sexual behavior in female rats.毒蕈碱受体亚型与雌性大鼠的性行为
Pharmacol Biochem Behav. 1991 Jan;38(1):115-24. doi: 10.1016/0091-3057(91)90598-v.
9
No evidence for a role of muscarinic M2 receptors in functional antagonism in bovine trachea.没有证据表明毒蕈碱M2受体在牛气管功能拮抗中起作用。
Br J Pharmacol. 1995 Jun;115(4):665-71. doi: 10.1111/j.1476-5381.1995.tb14984.x.
10
Central muscarinic receptor subtypes and carrageenin-induced paw oedema in rats.中枢毒蕈碱受体亚型与角叉菜胶诱导的大鼠爪肿胀
Res Exp Med (Berl). 1991;191(1):65-76. doi: 10.1007/BF02576660.

本文引用的文献

1
Effects of muscarinic receptor agonists and antagonists on swim-stress-induced 'behavioural despair' in rats.毒蕈碱受体激动剂和拮抗剂对游泳应激诱导的大鼠“行为绝望”的影响。
J Psychopharmacol. 1991 Jan;5(1):77-81. doi: 10.1177/026988119100500111.
2
Selective impairment of acetylcholine release and content in the central nervous system following intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) in the rat.大鼠脑室内注射氮芥胆碱吖啶离子(AF64A)后中枢神经系统中乙酰胆碱释放和含量的选择性损伤
Neurochem Int. 1986;8(2):199-206. doi: 10.1016/0197-0186(86)90164-6.
3
Muscarinic receptor activation inhibits both release and synthesis of noradrenaline in rat hippocampal synaptosomes.
毒蕈碱受体激活可抑制大鼠海马突触体中去甲肾上腺素的释放和合成。
Neurochem Int. 1986;8(2):171-7. doi: 10.1016/0197-0186(86)90161-0.
4
Alzheimer's disease: a disorder of cortical cholinergic innervation.阿尔茨海默病:一种皮质胆碱能神经支配障碍。
Science. 1983 Mar 11;219(4589):1184-90. doi: 10.1126/science.6338589.
5
Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.阿尔茨海默型痴呆患者死后大脑中生物胺及其代谢产物的变化。
J Neurochem. 1984 Aug;43(2):388-93. doi: 10.1111/j.1471-4159.1984.tb00913.x.
6
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.调节大鼠脑内神经递质释放的突触前毒蕈碱受体的异质性
J Pharmacol Exp Ther. 1984 Jan;228(1):209-14.
7
Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.阿尔茨海默型痴呆、抑郁症患者及自杀者大脑中的神经递质受体和单胺代谢产物。
Neuropharmacology. 1984 Dec;23(12B):1561-9. doi: 10.1016/0028-3908(84)90100-x.
8
Temperature responses to monoamines and an inhibitor of MAO injected into the cerebral ventricles of rats.对注入大鼠脑室的单胺类物质和单胺氧化酶抑制剂的温度反应。
Br J Pharmacol Chemother. 1967 Sep;31(1):152-61. doi: 10.1111/j.1476-5381.1967.tb01985.x.
9
On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties.关于大脑皮层中存在神经元定位、功能和药理学特性不同的毒蕈碱受体亚型。
J Pharmacol Exp Ther. 1985 Oct;235(1):230-3.
10
Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.
J Pharmacol Exp Ther. 1987 Jul;242(1):257-62.